• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number 26920
Device Problems Fracture (1260); Migration (4003)
Patient Problems Pain (1994); Thrombosis/Thrombus (4440)
Event Date 08/01/2022
Event Type  Injury  
Event Description
It was reported that the patient felt pain and a device fracture was observed.On (b)(6) a 7x80x75 innova self expanding stent was implanted into the patient's axillary vein.Following the procedure, the patient felt pain at the implant site and went to the hospital on (b)(6) an examination found the implanted stent was fractured.The patient was treated through additional procedures.Further information has been requested but has not been provided at this time.
 
Event Description
It was reported that the patient felt pain and a device fracture was observed.On may 21st, an 7x80x75 innova self expanding stent was implanted into the patient's axillary vein.Following the procedure, the patient felt pain at the implant site and went to the hospital on august 2nd.As a result of the examination, the implanted stent was fractured and the patient was treated through additional procedures.Further information has been requested but has not been provided at this time.It was further reported that the patient first started feeling pain at the implant site on august 1st and was admitted to the hospital on august 2nd.The fractured stent had migrated, and a blood clot formed between the blood vessel and the stent.An additional percutaneous transluminal angioplasty procedure was performed; however, after that, a blood clot occurred again and another non-boston scientific 8mm stent was implanted.Additional stenting was successfully completed despite the stenotic region in the mildly tortuous 6x70 vessel.Clopidogrel and aspirin were given post stenting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INNOVA
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15473248
MDR Text Key300556426
Report Number2124215-2022-37418
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeKS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/23/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number26920
Device Catalogue Number26920
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/22/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age52 YR
Patient SexMale
-
-